United States · Business magazines · Quartz

3 next-generation weight-loss drugs at different stages of FDA review and trials

Published by Quartz · United States 2 h ago

The next weight-loss drugs to watch are CagriSema, retatrutide and aleniglipron, three obesity candidates at different stages of testing and FDA review, and only one has been filed

Read the full article on Quartz Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (qz.com)

Also worth reading

Inc.

The Johns Hopkins Breach Wasn’t Caused by a Hacker. It Started With 1 Employee Upload

Kiplinger

The AI Boom Has a Warning System. Here's What It's Saying Now

Fox Business

Nelson Peltz-led group offers to buy Wendy’s for $1.4B

Fast Company

Daylight saving time is spooky this year: What to know about the 2026 clock change

Entrepreneur

McDonald’s Says There’s Such a Thing as a Bad Big Mac. Now It’s Training 2 Million Workers to Taste the Difference.

Markets Insider (Business Insider)